Leslie Spry
Impact in
- Nephrology top 10%
- Dialysis and Renal Disease Management
- Clinical Biochemistry top 10%
- Metabolism and Genetic Disorders
Papers in
-
- Genomics, phytochemicals, and oxidative stress 3
- Ion Transport and Channel Regulation 2
-
- Dialysis and Renal Disease Management 5
- Co-authors
- Aubrey R. Morrison (1 shared paper)Julio E. Benabe (1 shared paper)Terry V. Zenser (9 shared papers)Alison Steiber (3 shared papers)Alan T. Davis (2 shared papers)Bernard B. Davis (7 shared papers)Lorraine Weatherspoon (2 shared papers)Sachin Wani (1 shared paper)
- Journals
- Carcinogenesis (2 papers)Journal of the American Society of Nephrology (1 paper)Journal of Biological Chemistry (1 paper)Drug Metabolism and Disposition (1 paper)Biochemical Pharmacology (1 paper)
- Partner nations
- United StatesPuerto RicoAruba
In The Last Decade
Leslie Spry
24 papers receiving 278 citations
Peers
Comparison fields: 5 of 73
- Nephrology 77
- Clinical Biochemistry 49
- Pharmacology 33
- Emergency Medical Services 20
- Biochemistry 21
Countries citing papers authored by Leslie Spry
This map shows the geographic impact of Leslie Spry's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Leslie Spry with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Leslie Spry more than expected).
Fields of papers citing papers by Leslie Spry
This network shows the impact of papers produced by Leslie Spry. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Leslie Spry. The network helps show where Leslie Spry may publish in the future.
Co-authors
The 25 scholars most cited alongside Leslie Spry, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 26 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 1982 | 57 | |
| 2 | 2006 | 36 | |
| 3 | 2006 | 33 | |
| 4 | 2000 | 26 | |
| 5 | 2011 | 20 | |
| 6 | 2003 | 16 | |
| 7 | 1990 | 16 | |
| 8 | 1985 | 14 | |
| 9 | 2014 | 13 | |
| 10 | 2020 | 13 | |
| 11 | 2007 | 12 | |
| 12 | Effect of peroxidase inhibitors on an in vivo metabolite of the urinary bladder carcinogen N-[4-(5-nitro-2-furyl)-2-thiazolyl]formamide in rats. | 1988 | 10 |
| 13 | 1986 | 5 | |
| 14 | 2023 | 5 | |
| 15 | 1984 | 5 | |
| 16 | 2022 | 5 | |
| 17 | 1988 | 4 | |
| 18 | 2008 | 4 | |
| 19 | 2015 | 3 | |
| 20 | 1985 | 2 |
About Leslie Spry
Leslie Spry is a scholar working on Molecular Biology, Nephrology, Clinical Biochemistry, Pharmacology and Pharmacology, having authored 26 papers that have together received 304 indexed citations. Recurring topics across this work include Dialysis and Renal Disease Management (5 papers), Metabolism and Genetic Disorders (4 papers), Pharmacogenetics and Drug Metabolism (4 papers), Nitric Oxide and Endothelin Effects (3 papers), Genomics, phytochemicals, and oxidative stress (3 papers), Drug Transport and Resistance Mechanisms (3 papers), Ion Transport and Channel Regulation (2 papers) and Inflammatory mediators and NSAID effects (2 papers). The work is most often cited by research in Nephrology (77 citations), Clinical Biochemistry (49 citations), Pharmacology (33 citations), Emergency Medical Services (20 citations) and Biochemistry (21 citations). Leslie Spry has collaborated with scholars based in United States, Puerto Rico and Aruba. Frequent co-authors include Aubrey R. Morrison, Julio E. Benabe, Terry V. Zenser, Alison Steiber, Alan T. Davis, Bernard B. Davis, Lorraine Weatherspoon, Sachin Wani, Jennifer Strong and Samuel M. Cohen. Their work appears in journals such as Carcinogenesis, Journal of the American Society of Nephrology, Journal of Biological Chemistry, Drug Metabolism and Disposition and Biochemical Pharmacology.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.